Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 28;8(4):1639-1647.
doi: 10.1021/acssensors.2c02780. Epub 2023 Mar 26.

Continuous Measurement of Lactate Concentration in Human Subjects through Direct Electron Transfer from Enzymes to Microneedle Electrodes

Affiliations

Continuous Measurement of Lactate Concentration in Human Subjects through Direct Electron Transfer from Enzymes to Microneedle Electrodes

David M E Freeman et al. ACS Sens. .

Abstract

Microneedle lactate sensors may be used to continuously measure lactate concentration in the interstitial fluid in a minimally invasive and pain-free manner. First- and second-generation enzymatic sensors produce a redox-active product that is electrochemically sensed at the electrode surface. Direct electron transfer enzymes produce electrons directly as the product of enzymatic action; in this study, a direct electron transfer enzyme specific to lactate has been immobilized onto a microneedle surface to create lactate-sensing devices that function at low applied voltages (0.2 V). These devices have been validated in a small study of human volunteers; lactate concentrations were raised and lowered through physical exercise and subsequent rest. Lactazyme microneedle devices show good agreement with concurrently obtained and analyzed serum lactate levels.

Keywords: biosensor; continuous monitoring; direct electron transfer enzyme; in-human study; lactate; microneedles.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following competing financial interest(s): AEGC is the founder of a company, Continuous Diagnostics Ltd., involved in commercialisation of microneedle sensing devices. AKGF is the co-founder of a company, DirectSens GmbH, involved in commercialisation of enzyme-based sensor technology.

Figures

Figure 1
Figure 1
Pictures of the lactate-sensing microneedle device after (A) and before (B) functionalization, laser-cut electrical tape for insulating the base of the patch (C), the patch as used in vivo (D), and the back (E) and front (F) of the patch with a PCB attached.
Figure 2
Figure 2
(A) Current density vs lactate concentration for devices with varying levels of cellulose acetate applied in acetone solution: 0% w/v (red), 0.3% w/v (yellow), and 3% w/v (green). (B) Current density vs lactate concentration of averaged results of three devices using 3% w/v cellulose acetate in acetone as a diffusion-limiting layer. Markers represent mean ± standard deviation (n = 3). All results are fitted with Michaelis–Menten equation, values of Km and Vmax are given in mM and μA/mm2, respectively, and the error represents 1 standard deviation.
Figure 3
Figure 3
In vivo data from continuous microneedle measurement (raw data in light blue and Savitzky–Golay 2501-point second-order filtered data in dark blue) with blood lactate concentrations (red crosses) measured by a photometric lactate assay through an Architect Ci8200 from blood draws on five participants (A–E); the resistance of the bike was modulated to increase or decrease the work performed (green). Lactate levels were raised through exercise on an exercise bike (F).
Figure 4
Figure 4
In vitro calibrations of the microneedle device against acetaminophen (A) and ascorbic acid (B) at 0.2 V. Dotted lines denote time points of the addition of stock solution to adjust the concentration to the level shown.

Similar articles

Cited by

References

    1. Schollin-Borg M.; Nordin P.; Zetterström H.; Johansson J. Blood Lactate Is a Useful Indicator for the Medical Emergency Team. Crit. Care Res. Pract. 2016, 576520210.1155/2016/5765202. - DOI - PMC - PubMed
    1. Dettmer M.; Holthaus C. V.; Fuller B. M. The impact of serial lactate monitoring on emergency department resuscitation interventions and clinical outcomes in severe sepsis and septic shock: an observational cohort study. Shock 2015, 43, 55–61. 10.1097/SHK.0000000000000260. - DOI - PMC - PubMed
    1. Chertoff J.; Chisum M.; Garcia B.; Lascano J. Lactate kinetics in sepsis and septic shock: a review of the literature and rationale for further research. J. Intensive Care 2015, 3, 39.10.1186/s40560-015-0105-4. - DOI - PMC - PubMed
    1. Kruse O.; Grunnet N.; Barfod C. Blood lactate as a predictor for in-hospital mortality in patients admitted acutely to hospital: a systematic review. Scand. J. Trauma, Resusc. Emerg. Med. 2011, 19, 74.10.1186/1757-7241-19-74. - DOI - PMC - PubMed
    1. Lee S. M.; An W. S. New clinical criteria for septic shock: serum lactate level as new emerging vital sign. J. Thorac. Dis. 2016, 8, 1388–1390. 10.21037/jtd.2016.05.55. - DOI - PMC - PubMed

Publication types